In The News
In The News
UM171 saves another life


Developed in Canada, the UM171 molecule was used in a blood transplant by a Montreal medical team on a young man suffering from severe aplastic anemia, an autoimmune disease.

Read more

ExCellThera’s presentation at Meeting on the Mesa 2019 (video)


Presented by Guy Sauvageau, Founder and CEO on October 2, 2019

Read more

Molécule pour traiter des patients atteints de leucémie aigüe


Molécule pour traiter des patients atteints de leucémie aigüe : Anne Marinier, chercheuse et Monique Russier, patiente. 98,5 Montréal

Read more

ExCellThera’s safer allogeneic transplants


ExCellThera Inc. is expanding cord blood into allogeneic stem cell transplants for cancer that have lower treatment-related mortality rates and GvHD incidence … BioCentury (paywalled)

Read more

La recherche à l’IRIC : les travaux de Guy Sauvageau


Découvrez à travers la vidéo réalisée par l’Université de Montréal, les travaux de recherche menés par le Docteur Guy Sauvageau. IRIC video

Read more

Dalton Pharma Services enters into a drug development and manufacturing services agreement with ExCellThera Inc.


This agreement provides ExCellThera access to Dalton’s State-of-the-Art cGMP, Health Canada approved biopharmaceutical facility in Toronto, ON, Canada. Under the agreement terms… PRWeb

Read more

ExCellThera Founder and CEO, Guy Sauvageau, elected member of the Academy of Science, Royal Society of Canada


Dr. Guy Sauvageau, Principal Investigator at the Institute for Research in Immunology and Cancer (IRIC) … has been elected a member of the Academy of Science of the Royal Society of Canada (RSC)… Markets Insider

Read more

Canadian cord-blood procedure passes key milestone in cancer trial


Researchers behind a made-in-Canada technology for multiplying the number of stem cells … The Globe and Mail

Read more

Cancer: une molécule québécoise aux résultats «extraordinaires»


On connaît la multiplication des pains racontée dans les Évangiles. Mais voilà que des chercheurs québécois croient pouvoir sauver des vies grâce à un autre miracle : la multiplication des cellules souches dans le sang des cordons ombilicaux… La Presse

Read more

Start-ups – Des jeunes pousses déjà grandes


ExcellThera dévoilera sous peu les résultats de sa première étude clinique portant sur 25 patients atteints d’une forme de leucémie… La Presse

Read more

A molecule of hope: Université de Montréal researchers discover a method to increase quantity of cord blood stem cells


Umbilical cord blood, previously discarded, has been seen in more recent years as a useful source for blood stem cells. It contains haematopoietic stem cells that are usually … Biotechnology Focus

Read more

A multitiered approach to stem cell discoveries


A multitiered approach to stem cell discoveries. MaRS Magazine

Read more

The success of ExCellThera featured in Bio Business


Returning to form: New funding gives hope for 10 new therapies over the next 10 years, Bio Business

Read more

ExCellThera in BioWorld Today


In the Clinic: ExCellThera. BioWorld Today (page 12)

Read more

Banking on cord blood


Recent innovations in the ability to expand the usable stem cells within a unit of cord blood may make the life-giving cells available to a much greater number of patients … Ontario Institute for Regenerative Medicine

Read more

ExCellThera veut transformer la greffe de cellules souches


Québec: ExCellThera veut transformer la greffe de cellules souches. BiotechFinances

Read more

Les 10 découvertes 2014


Une manne de cellules souches, Québec Science

Read more

Scroll to view